Glucose Health, Inc. (OTCMKTS:GLUC – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $0.36 and traded as high as $0.44. Glucose Health shares last traded at $0.44, with a volume of 10,011 shares trading hands.
Key Headlines Impacting Glucose Health
Investors following GLUC have been watching these headlines:
- Neutral Sentiment: A report says weekly specially prepared meals were associated with lower blood sugar and blood pressure among 110 people. It is general health coverage, not news of a GLUC product or partnership. 110 people received specially prepared meals every week: Both blood sugar and blood pressure dropped
- Neutral Sentiment: Other coverage discusses blood-sugar fluctuations, diabetes risks and symptoms, diet and drinks, physical activity, air filtration, and mobile coaching. These broad health topics may sustain interest in glucose management, but the articles provide no direct evidence of an impact on GLUC’s business. The science behind blood sugar fluctuations and energy levels · Diabetes and bladder health: How high blood sugar affects urination · Rising type-2 diabetes cases in Chandigarh youth linked to sedentary lifestyles · The Best After-Dinner Drink for Stable Blood Sugar · Your air purifier could stop you getting diabetes, study finds · Personalized mobile health coaching offers new approach to preventing gestational diabetes in high-risk pregnancies
Glucose Health Price Performance
The firm has a market cap of $8.83 million, a price-to-earnings ratio of -10.33 and a beta of 1.30. The firm has a fifty day simple moving average of $0.37 and a two-hundred day simple moving average of $0.36.
Glucose Health (OTCMKTS:GLUC – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.04 million during the quarter.
About Glucose Health
Glucose Health, Inc. is a consumer health company focused on developing, marketing and selling nutritional supplements intended to support healthy blood glucose levels and overall metabolic health. The company’s product portfolio has included dietary supplement formulations marketed under the GlucoCil brand. These products are positioned as complementary wellness solutions for adults seeking nutritional support for blood sugar management and related health goals. Glucose Health primarily markets its products through direct-to-consumer and online channels.
See Also
- Five stocks we like better than Glucose Health
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.
